Suppr超能文献

异噻唑啉酮(IZD)作为鼠疫耶尔森菌蛋白酪氨酸磷酸酶YopH抑制剂中的磷酰基模拟物。

Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH.

作者信息

Kim Sung Eun, Bahta Medhanit, Lountos George T, Ulrich Robert G, Burke Terrence R, Waugh David S

机构信息

Chemical Biology Laboratory, National Cancer Institute at Frederick, MD 21702-1201, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2011 Jul;67(Pt 7):639-45. doi: 10.1107/S0907444911018610. Epub 2011 Jun 11.

Abstract

Isothiazolidinone (IZD) heterocycles can act as effective components of protein tyrosine phosphatase (PTP) inhibitors by simultaneously replicating the binding interactions of both a phosphoryl group and a highly conserved water molecule, as exemplified by the structures of several PTP1B-inhibitor complexes. In the first unambiguous demonstration of IZD interactions with a PTP other than PTP1B, it is shown by X-ray crystallography that the IZD motif binds within the catalytic site of the Yersinia pestis PTP YopH by similarly displacing a highly conserved water molecule. It is also shown that IZD-based bidentate ligands can inhibit YopH in a nonpromiscuous fashion at low micromolar concentrations. Hence, the IZD moiety may represent a useful starting point for the development of YopH inhibitors.

摘要

异噻唑啉酮(IZD)杂环可通过同时模拟磷酸基团和高度保守水分子的结合相互作用,充当蛋白酪氨酸磷酸酶(PTP)抑制剂的有效成分,几种PTP1B抑制剂复合物的结构即为例证。在首次明确证明IZD与PTP1B以外的其他PTP相互作用时,X射线晶体学表明,IZD基序通过类似地取代一个高度保守的水分子,结合在鼠疫耶尔森菌PTP YopH的催化位点内。还表明基于IZD的双齿配体可以低微摩尔浓度以非混杂方式抑制YopH。因此,IZD部分可能是开发YopH抑制剂的有用起点。

相似文献

6
Structure of the N-terminal domain of Yersinia pestis YopH at 2.0 A resolution.鼠疫耶尔森菌YopH N端结构域在2.0埃分辨率下的结构
Acta Crystallogr D Biol Crystallogr. 2001 Jun;57(Pt 6):793-9. doi: 10.1107/s0907444901004875. Epub 2001 May 25.

引用本文的文献

1
Citric Acid Controls the Activity of YopH Bacterial Tyrosine Phosphatase.柠檬酸控制 YopH 细菌酪氨酸磷酸酶的活性。
Drug Des Devel Ther. 2024 Apr 11;18:1165-1174. doi: 10.2147/DDDT.S444500. eCollection 2024.
7
Structure of human dual-specificity phosphatase 7, a potential cancer drug target.人类双特异性磷酸酶7的结构,一种潜在的癌症药物靶点。
Acta Crystallogr F Struct Biol Commun. 2015 Jun;71(Pt 6):650-6. doi: 10.1107/S2053230X1500504X. Epub 2015 May 20.

本文引用的文献

1
The MORPHEUS protein crystallization screen.MORPHEUS蛋白质结晶筛选
J Appl Crystallogr. 2009 Dec 1;42(Pt 6):1035-1042. doi: 10.1107/S0021889809042022. Epub 2009 Nov 7.
2
REFMAC5 for the refinement of macromolecular crystal structures.用于大分子晶体结构精修的REFMAC5
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. doi: 10.1107/S0907444911001314. Epub 2011 Mar 18.
4
Derivatives of salicylic acid as inhibitors of YopH in Yersinia pestis.水杨酸衍生物作为鼠疫耶尔森氏菌 YopH 的抑制剂。
Chem Biol Drug Des. 2010 Aug;76(2):85-99. doi: 10.1111/j.1747-0285.2010.00996.x. Epub 2010 Jun 18.
7
Molecular replacement with MOLREP.使用MOLREP进行分子置换。
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5. doi: 10.1107/S0907444909042589. Epub 2009 Dec 21.
8
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验